Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Antibacterials for systemic use: consumption in Lithuania 2017

Consumption of antibacterials for systemic use in Lithuania in 2017 (in DDD per 1,000 inhabitants per day)

by Conor Stewart, last edited Jun 27, 2019
Antibacterials for systemic use: consumption in Lithuania 2017 This statistic displays the consumption of antibacterials for systemic use in the community and in the hospital sector in Lithuania in 2017. The defined daily dose (DDD) of tetracyclines per 1,000 inhabitants per day in the community (primary care sector) in Lithuania amounted to 1.40 in 2017.
Show more

Consumption of antibacterials for systemic use in Lithuania in 2017 (in DDD per 1,000 inhabitants per day)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Antibiotic use in the United Kingdom (UK)"
  • Overview
The most important statistics
  • Antiobiotic consumption
  • Antibiotic use
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.